-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Friday, INNOVATE Announces FDA Approval Of MediBeacon's TGFR System For Accurate Kidney Function Testing

Benzinga·01/21/2025 07:02:54
Listen to the news
  • Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function
  • The transdermal GFR (tGFR) methodology has been designed to be effective across the adult population without input of age, weight, sex, gender, race, or ethnicity
  • More than 800 million people have Chronic Kidney Disease (CKD), one of the world's leading causes of mortality worldwide, with associated deaths increasing over the past two decades1